Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271980
Max Phase: Preclinical
Molecular Formula: C17H28N6O3
Molecular Weight: 364.45
Associated Items:
ID: ALA5271980
Max Phase: Preclinical
Molecular Formula: C17H28N6O3
Molecular Weight: 364.45
Associated Items:
Canonical SMILES: CCCCOc1nc(N)c2[nH]c(=O)n(CCCCN3CCOCC3)c2n1
Standard InChI: InChI=1S/C17H28N6O3/c1-2-3-10-26-16-20-14(18)13-15(21-16)23(17(24)19-13)7-5-4-6-22-8-11-25-12-9-22/h2-12H2,1H3,(H,19,24)(H2,18,20,21)
Standard InChI Key: GPPJVROJVRJFAI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 364.45 | Molecular Weight (Monoisotopic): 364.2223 | AlogP: 0.99 | #Rotatable Bonds: 9 |
Polar Surface Area: 111.29 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.34 | CX Basic pKa: 7.51 | CX LogP: 1.85 | CX LogD: 1.49 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.64 | Np Likeness Score: -1.17 |
1. Biggadike K, Ahmed M, Ball DI, Coe DM, Dalmas Wilk DA, Edwards CD, Gibbon BH, Hardy CJ, Hermitage SA, Hessey JO, Hillegas AE, Hughes SC, Lazarides L, Lewell XQ, Lucas A, Mallett DN, Price MA, Priest FM, Quint DJ, Shah P, Sitaram A, Smith SA, Stocker R, Trivedi NA, Tsitoura DC, Weller V.. (2016) Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma., 59 (5): [PMID:26861551] [10.1021/acs.jmedchem.5b01647] |
Source(1):